XML 21 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Current assets    
Cash $ 4,947,417 $ 1,690,866
Marketable securities, at fair value 2,011,529 803,664
Prepaid expenses 56,737 110,072
Deferred offering cost 30,484
Total current assets 7,015,683 2,635,086
Property and equipment, net 433 1,043
Investment in joint venture 410,000
Restricted cash 200,000
Total assets 7,426,116 2,836,129
Current liabilities    
Accounts payable 180,093 403,885
Accrued expenses 125,000 36,236
Accrued license fee - current portion 50,000
Total current liabilities 355,093 440,121
Accrued license fee 235,000
Total liabilities 590,093 440,121
Commitments and contingencies
Stockholders' equity    
Common stock, $0.0001 par value, 75,000,000 shares authorized, 13,433,267 and 10,119,844 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively 1,343 1,012
Additional paid-in-capital 23,375,090 14,610,638
Accumulated deficit (16,539,748) (12,215,642)
Accumulated other comprehensive loss (662)
Total stockholders' equity 6,836,023 2,396,008
Total liabilities and stockholders' equity 7,426,116 2,836,129
Series A Convertible Preferred Stock    
Stockholders' equity    
Preferred stock, $0.0001 par value, 5,000,000 shares authorized, 0 shares issued and outstanding at June 30, 2020 and December 31, 2019, respectively